We designed the Framework to create significant value for shareholders by focusing our portfolio and leveraging our financial strength.
The increase in both periods was led by the Optical Communications segment, which increased $141 million and $209 million, respectively, due to higher sales of carrier network products in North American and Europe, and an increase in sales of enterprise network products from growth in data centers.
Life Sciences sales increased by $24 million and $46 million, respectively, driven by higher sales across all product lines.
Net sales in the Display Technologies and Specialty Materials segments increased by $3 million and $6 million, respectively, for the three months ended June 30, 2018.
Diluted earnings per share increased by $0.36 per share, or 86%, when compared to the second quarter of 2017, driven by the increase in net income described above, coupled with the repurchase of 24.6 million shares of common stock for approximately $674 million.
We believe 2018 will be another year of strong growth and investment, consistent with our Strategy and Capital Allocation Framework, and anticipate that segment net sales will reach approximately $11.3 billion, an increase from prior expectations of $11.0 billion.
In our Display Technologies segment, we expect pricing to continue to improve, with year-over-year declines reaching mid-single digits in the third quarter, an important milestone toward our goal of stabilizing returns.
We anticipate Corning’s LCD glass volume will grow faster than the expected LCD glass market growth of mid-single digits, driven by the ramp of our Gen 10.5 facility in China.
In the Optical Communications segment, we expect sales to increase in the high-teen percentage range with organic growth improving by a low-teen percentage range with an additional $200 million from the acquisition of 3M’s Communications Market Division, driven by strong demand from carrier and enterprise network customers.
Movements in foreign exchange rates impacted Corning’s consolidated net sales in the amount of $50 million in the three months ended June 30, 2018, when compared to the prior year.
·    An increase of $46 million in the Life Sciences segment, driven by higher sales in North America, Europe and China.
Movements in foreign exchange rates impacted Corning’s consolidated net sales in the amount of $137 million in the six months ended June 30, 2018, when compared to the prior year.
In the three and six months ended June 30, 2018, gross margin increased by $85 million, or 9%, and $89 million, or 5%, respectively, primarily driven by an increase in sales.
·    An increase of $13 million in corporate spending primarily related to new information technology platforms and outside legal fees.
As a percentage of sales, these expenses increased slightly when compared to the same period last year.
As a percentage of sales, these expenses increased slightly when compared to the same period last year.See our 2017 Form 10-K, Part I, Item 3.